Endoscopy 2022; 54(S 01): S225
DOI: 10.1055/s-0042-1745203
Abstracts | ESGE Days 2022
ESGE Days 2022 Digital poster exhibition

EFFICACY AND SAFETY OF DIGITAL SINGLE-OPERATOR CHOLANGIOPANCREATOSCOPY IN ELDERLY PATIENTS IN A TERTIARY REFERRAL CENTER

M. Gesualdo
1   AOU Città della Salute e della Scienza, University of Turin, Division of Gastroenterology, Endoscopy Unit, Turin, Italy
,
M. Sacco
1   AOU Città della Salute e della Scienza, University of Turin, Division of Gastroenterology, Endoscopy Unit, Turin, Italy
,
E. Dall'Amico
1   AOU Città della Salute e della Scienza, University of Turin, Division of Gastroenterology, Endoscopy Unit, Turin, Italy
,
F. Cravero
1   AOU Città della Salute e della Scienza, University of Turin, Division of Gastroenterology, Endoscopy Unit, Turin, Italy
,
M.T. Staiano
1   AOU Città della Salute e della Scienza, University of Turin, Division of Gastroenterology, Endoscopy Unit, Turin, Italy
,
F. Fimiano
1   AOU Città della Salute e della Scienza, University of Turin, Division of Gastroenterology, Endoscopy Unit, Turin, Italy
,
A. Mauriello
1   AOU Città della Salute e della Scienza, University of Turin, Division of Gastroenterology, Endoscopy Unit, Turin, Italy
,
F. Castellano
1   AOU Città della Salute e della Scienza, University of Turin, Division of Gastroenterology, Endoscopy Unit, Turin, Italy
,
C.G. De Angelis
1   AOU Città della Salute e della Scienza, University of Turin, Division of Gastroenterology, Endoscopy Unit, Turin, Italy
› Author Affiliations
› Further Information
Also available at
 

Aims Digital single-operator cholangioscopy (DSOC) became a key element in diagnosis and treatment of pancreato-biliary diseases, as difficult lithiasis or indeterminate strictures. Data about safety and efficacy of DSOC in patients older than 70 years are scanty; aim of this study is to assess safety and efficacy of DSOC in this population.

Methods All patients underwent DSOC in our tertiary referral center in Turin from January 2016 to October 2021 were retrospectively analyzed, extracting data from a prospective collected database.

We divided our cohort in two groups, group A (<70 years) and group B (≥70 years), comparing demographic and clinical data, technical success and complications rates with T-Student test or Fisher’s exact test where indicated.

Results 111 procedures were performed in 88 patients, 44 in each group; mean follow up was 12±14.9 months. Comorbidity rate, number of previous ERCP and indication for DSOC were comparable among groups ([Table 1]).

Technical success (the successful insertion of cholangioscope with the visualization of target) was similar among groups and was achieved in 55 procedures in group A (95%) and in 56 procedures in group B (100%, p 0.24). Six patients in group A (14%) and seven patients in group B (16%, p>0.99) experienced respectively 6 and 9 adverse events (10% vs 17%, p 0.41). Cholangitis was the most common adverse event in both groups. All adverse events were managed medically and/or endoscopically.

Table 1

Group A (n=44)

Group B (n=44)

p

Mean age, years±SD

59.1±9.8

78.1±5.7

<0.001

Number of previous ERCP, mean±SD

1.2±1.25

1.4±1.18

0.35

Patients with comorbidities, n (%)

23 (52%)

29 (66%)

0.19

Indication (Stricture/Lithiasis/Other), n (%)

15/23/5 (35% – 53% – 5%)

19/20/6 (42% – 45% – 13%)

0.43

Conclusions DSOC in elderly patients showed efficacy and safety profile comparable with those of younger patients.



Publication History

Article published online:
14 April 2022

© 2022. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany